IL6 and cancer: It triggers systemic changes like hyperglycemia and hyperinsulinemia and increases levels of adipose tissue-derived estrogens, adipokines, and inflammatory mediators (e.g., prostaglandin E2 [PGE2], tumor necrosis factor [TNF], and IL-6), stimulating cancer growth.44